T

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

27 citing papers in PubMed.

1. The resilient subset: cancer stem cells at the core of immunotherapy resistance.Immunotherapy advances · 2026
   Review
2. Connexin-43 in Cancer: Above and Beyond Gap Junctions!Cancers · 2024
   Review
3. Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression.Experimental hematology & oncology · 2024
   Review
4. Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules.Biomarker research · 2024
   Review
5. Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of Cancer stem cells.Cell communication and signaling : CCS · 2024
   Article
6. Immunobiology of cancer stem cells and their immunoevasion mechanisms.Molecular biology reports · 2023
   Review
7. Bone serves as a transfer station for secondary dissemination of breast cancer.Bone research · 2023
   Review
8. Increased expression of musashi 1 on breast cancer cells has implication to understand dormancy and survival in bone marrow.Aging · 2023
   Article
9. The Multifaceted Role of Connexins in Tumor Microenvironment Initiation and Maintenance.Biology · 2023
   Review
10. Targeting breast cancer stem cells directly to treat refractory breast cancer.Frontiers in oncology · 2023
    Review
11. Leveraging the scientific findings to develop therapeutic strategies for dormant breast cancer cells.Oncoscience · 2022
    Article
12. NFĸB Targeting in Bone Marrow Mesenchymal Stem Cell-Mediated Support of Age-Linked Hematological Malignancies.Stem cell reviews and reports · 2021
    Article
13. Relationship between Th17 immune response and cancer.World journal of clinical oncology · 2021
    Review
14. The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor.Stem cell research & therapy · 2021
    Review
15. Specific N-cadherin-dependent pathways drive human breast cancer dormancy in bone marrow.Life science alliance · 2021
    Article
16. The Relationship Between Mesenchymal Stem Cells and Tumor Dormancy.Frontiers in cell and developmental biology · 2021
    Review
17. Comparative immunomodulatory properties of mesenchymal stem cells derived from human breast tumor and normal breast adipose tissue.Cancer immunology, immunotherapy : CII · 2020
    Article
18. Mechanisms behind the Immunoregulatory Dialogue between Mesenchymal Stem Cells and Th17 Cells.Cells · 2020
    Review
19. An evolving paradigm of cancer stem cell hierarchies: therapeutic implications.Theranostics · 2020
    Review
20. The Multifaceted Roles of MSCs in the Tumor Microenvironment: Interactions With Immune Cells and Exploitation for Therapy.Frontiers in cell and developmental biology · 2020
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

7 authors.

Funding

Abstract